Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Sensors and Actuators. B, Chemical
|
September 16, 2016
Novel, high-quality surface plasmon resonance microscopy
Rahber Thariani, Paul Yager
Plos One
|
April 3, 2010
Imaging of surfaces by concurrent surface plasmon resonance and surface plasmon resonance-enhanced fluorescence
Rahber Thariani, Paul Yager
Pharmacoeconomics
|
October 13, 2010
Cost effectiveness of pharmacogenomics: a critical and systematic review
William B Wong, Josh J Carlson, Rahber Thariani, et al.
Molecular Oncology
|
March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectiveness
Rahber Thariani, David L Veenstra, Josh J Carlson, et al.
Journal of Comparative Effectiveness Research
|
November 19, 2013
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis
Rahber Thariani, Norah Lynn Henry, Scott D Ramsey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 6, 2012
Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research
Laura C Esmail, Josh Roth, Sneha Rangarao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2014
Tumor marker usage and medical care costs among older early-stage breast cancer survivors
Scott D Ramsey, N Lynn Henry, Julie R Gralow, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 3, 2013
Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics
Josh J Carlson, Rahber Thariani, Josh Roth, et al.
Pharmacogenomics
|
June 11, 2013
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation
Talitha I Verhoef, William K Redekop, David L Veenstra, et al.
Medical Care
|
January 26, 2012
Prioritization in comparative effectiveness research: the CANCERGEN Experience
Rahber Thariani, William Wong, Josh J Carlson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Sensors and Actuators. B, Chemical
|
September 16, 2016
Novel, high-quality surface plasmon resonance microscopy
Rahber Thariani, Paul Yager
Plos One
|
April 3, 2010
Imaging of surfaces by concurrent surface plasmon resonance and surface plasmon resonance-enhanced fluorescence
Rahber Thariani, Paul Yager
Pharmacoeconomics
|
October 13, 2010
Cost effectiveness of pharmacogenomics: a critical and systematic review
William B Wong, Josh J Carlson, Rahber Thariani, et al.
Molecular Oncology
|
March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectiveness
Rahber Thariani, David L Veenstra, Josh J Carlson, et al.
Journal of Comparative Effectiveness Research
|
November 19, 2013
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis
Rahber Thariani, Norah Lynn Henry, Scott D Ramsey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 6, 2012
Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research
Laura C Esmail, Josh Roth, Sneha Rangarao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2014
Tumor marker usage and medical care costs among older early-stage breast cancer survivors
Scott D Ramsey, N Lynn Henry, Julie R Gralow, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 3, 2013
Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics
Josh J Carlson, Rahber Thariani, Josh Roth, et al.
Pharmacogenomics
|
June 11, 2013
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation
Talitha I Verhoef, William K Redekop, David L Veenstra, et al.
Medical Care
|
January 26, 2012
Prioritization in comparative effectiveness research: the CANCERGEN Experience
Rahber Thariani, William Wong, Josh J Carlson, et al.
Page
of 1